Clinical Trial Update: Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pembrolizumab combined with photodynamic therapy in previously treated metastatic esophageal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Peking University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN